JP2013504537A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504537A5
JP2013504537A5 JP2012528352A JP2012528352A JP2013504537A5 JP 2013504537 A5 JP2013504537 A5 JP 2013504537A5 JP 2012528352 A JP2012528352 A JP 2012528352A JP 2012528352 A JP2012528352 A JP 2012528352A JP 2013504537 A5 JP2013504537 A5 JP 2013504537A5
Authority
JP
Japan
Prior art keywords
hydroxy
dihydro
pyrrolo
oxo
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504537A (ja
Filing date
Publication date
Priority claimed from GBGB0915892.4A external-priority patent/GB0915892D0/en
Application filed filed Critical
Publication of JP2013504537A publication Critical patent/JP2013504537A/ja
Publication of JP2013504537A5 publication Critical patent/JP2013504537A5/ja
Pending legal-status Critical Current

Links

JP2012528352A 2009-09-10 2010-09-08 Ampk活性化因子としてのピロロピリジン誘導体 Pending JP2013504537A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0915892.4 2009-09-10
GBGB0915892.4A GB0915892D0 (en) 2009-09-10 2009-09-10 Compounds
PCT/EP2010/063196 WO2011029855A1 (en) 2009-09-10 2010-09-08 Pyrrolo-pyridine derivatives as activators of ampk

Publications (2)

Publication Number Publication Date
JP2013504537A JP2013504537A (ja) 2013-02-07
JP2013504537A5 true JP2013504537A5 (enExample) 2013-10-24

Family

ID=41228136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528352A Pending JP2013504537A (ja) 2009-09-10 2010-09-08 Ampk活性化因子としてのピロロピリジン誘導体

Country Status (5)

Country Link
US (1) US20120172333A1 (enExample)
EP (1) EP2475660A1 (enExample)
JP (1) JP2013504537A (enExample)
GB (1) GB0915892D0 (enExample)
WO (1) WO2011029855A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2486631A (en) * 2010-12-01 2012-06-27 Univ Sheffield Phenol/quinone boronic acids/esters and method of preparation thereof
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
WO2014089495A1 (en) 2012-12-07 2014-06-12 Chemocentryx, Inc. Diazole lactams
EP2935227B1 (en) 2012-12-21 2017-09-13 ChemoCentryx, Inc. Diazole amides as ccr1 receptor antagonists
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
WO2015103480A1 (en) 2014-01-02 2015-07-09 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
US9980948B2 (en) 2014-08-27 2018-05-29 Shionogi & Co., Ltd. Azaindole derivative having AMPK-activating activity
PL3439653T3 (pl) 2016-04-07 2021-07-05 Chemocentryx, Inc. Zmniejszenie obciążenia guzem przez podawanie antagonistów ccr1 w skojarzeniu z inhibitorami pd-1 lub inhibitorami pd-l1
EP4066832A4 (en) * 2019-11-14 2024-01-03 Zincure Corp. Pharmaceutical composition for treating multiple sclerosis on basis of ampk inhibitory function and zinc homeostasis control function
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ,インク. Ampkアクチベーター
US11857346B2 (en) 2021-05-25 2024-01-02 Warsaw Orthopedic, Inc. Systems and methods for real-time monitoring of bone correction
EP4433458A4 (en) 2021-11-19 2025-10-29 Broad Inst Inc Bifunctional chimeric molecules for labeling kinases with target bond fractions and their methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096813A1 (en) * 2001-04-20 2003-05-22 Jingrong Cao Compositions useful as inhibitors of GSK-3
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
EP1723132A1 (en) 2004-02-12 2006-11-22 Asterand Uk Limited Ep2 receptor agonists
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
US8030346B2 (en) * 2007-05-04 2011-10-04 Amgen Inc. Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
EP2231666B1 (en) * 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
MY158994A (en) * 2008-02-04 2016-11-30 Mercury Therapeutics Inc Ampk modulators

Similar Documents

Publication Publication Date Title
JP2013504537A5 (enExample)
HRP20140593T1 (hr) Derivati 1,3-disupstituiranih imidazolidin-2-ona kao cyp 17-inhibitori
AU2010231630B2 (en) Medical composition for treatment or prophylaxis of glaucoma
JP6853619B2 (ja) シアノトリアゾール化合物の医薬用途
AU2007256708B2 (en) Organic compounds
JP6503336B2 (ja) シアノトリアゾール化合物
JP4408627B2 (ja) 置換アルキルアミン誘導体およびそれの使用方法
AU2009224329B2 (en) Pyridylaminoacetic acid compound
JP2016164184A5 (enExample)
CA2647338A1 (en) Integrase inhibitors-3
JP6466335B2 (ja) ROR−γ−Tのメチレン連結キノリニルモジュレーター
JP6251277B2 (ja) ROR−ガンマ−tのフェニル結合キノリニルモジュレーター
RU2011147206A (ru) Азетидинилдиамиды в качестве ингибиторов моноацилглицеринлипазы
RU2004112191A (ru) Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха
JP6067181B2 (ja) アルドステロンシンターゼ阻害薬
JP2009510161A5 (enExample)
JP2020526556A5 (enExample)
TW200529830A (en) A thiazole derivative
JP2014520885A5 (enExample)
JP2010513304A5 (enExample)
EP1537084A1 (en) Substituted 2-alkylamine nicotinic amide derivatives and use there of
JP2007518809A5 (enExample)
JP2007516173A5 (enExample)
JP2014532626A5 (enExample)
HRP20140035T1 (hr) Tieno[2,3-b]piridindion aktivatori ampk i njihove terapijske uporabe